Despite the market’s focus on stocks such as Micron and Apple, some investors are turning their attention to IBM.
The company has unveiled chip technology below 1 nanometer. The new architecture, referred to as “nanostack,” is intended to enable vertical stacking of transistors and further increases in computing density at a time when traditional semiconductor scaling is approaching physical limits.
According to IBM, the new 0.7 nm technology could fit up to 100 billion transistors on a chip the size of a fingernail. That is twice as many as the earlier 2 nm chip presented by the company in 2021. In its 2022 report, IBM indicated that it had signed a three-year joint development/licensing agreement with a Japanese consortium regarding IP and know-how in advanced semiconductors, which was expected to generate around USD 100 million in revenue in 2022. Monetizing the next phase of IBM’s technology development will take time, but it could be more impressive.
Other potential benefits include (estimated) 50% higher performance or up to 70% lower power consumption versus the 2 nm generation. Particularly in the context of AI, the claimed improvement in SRAM memory scaling may also matter, data bandwidth and efficiency are increasingly becoming key constraints on the development of AI accelerators.
From a technology standpoint, IBM’s announcement strengthens the long-term thesis that the semiconductor industry still has room to increase computing power despite growing constraints. For the AI market, this potentially means a further decline in the cost per unit of computation and greater data-center efficiency.
At the same time, the breakthrough is, for now, research-and-development in nature rather than commercial. Any deployment, mass production, and monetization are likely a matter of years and would probably occur mainly through technology licensing and cooperation with a foundry company (e.g., Intel).
In the short term, it is difficult to expect a significant impact on IBM’s revenues and margins. The information improves perceptions of the company’s technological capabilities and strengthens its position in strategic areas, including AI. Over time, the breakthrough may also start to support the broader market, which is questioning the rationale and quality of hyperscalers’ capital expenditures.
IBM.US (D1)
The market reaction is muted. The stock initially gained about 2% in Thursday’s session, but as overall sentiment deteriorated, the price move turned downward. The stock remains in a broad rising trend channel and a consolidation channel between $330 and $220, currently closer to its lower boundary. Source: xStation5.
Daily summary: Semiconductors are swallowing Wall Street
Apple Price Hikes: Memory costs weigh on the company’s and markets
Micron earnings: Is perfection not enough anymore?
US OPEN: Micron is not enough, Wall Street deepens declines
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
